BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18097517)

  • 21. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dependence of EGF-induced increases in corneal epithelial proliferation and migration on GSK-3 inactivation.
    Wang Z; Yang H; Zhang F; Pan Z; Capó-Aponte J; Reinach PS
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4828-35. PubMed ID: 19443725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
    Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
    Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle.
    Yang M; Huang HL; Zhu BY; Tuo QH; Liao DF
    Acta Pharmacol Sin; 2005 Feb; 26(2):205-11. PubMed ID: 15663900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
    MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
    Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
    Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
    Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
    Yan TZ; Jin FS; Xie LP; Li LC
    Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
    Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
    Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.
    Choi J; Park SY; Joo CK
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2696-704. PubMed ID: 15277494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C; Klein EA; Assoian RK; Kazanietz MG
    Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1.
    Corona G; Deiana M; Incani A; Vauzour D; Dessì MA; Spencer JP
    Mol Nutr Food Res; 2009 Jul; 53(7):897-903. PubMed ID: 19685549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells.
    Chen RJ; Ho YS; Guo HR; Wang YJ
    Toxicol Sci; 2008 Aug; 104(2):283-93. PubMed ID: 18448488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The duration of nuclear extracellular signal-regulated kinase 1 and 2 signaling during cell cycle reentry distinguishes proliferation from apoptosis in response to asbestos.
    Yuan Z; Taatjes DJ; Mossman BT; Heintz NH
    Cancer Res; 2004 Sep; 64(18):6530-6. PubMed ID: 15374964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
    Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
    Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.